The recent wave of National Institutes of Health (NIH) grant terminations has created an unprecedented crisis in American medical research, stripping nearly $2 billion in critical funding from U.S. medical schools and hospitals. This…
Continue Reading
The American healthcare system faces an unprecedented crisis as proposed changes to federal health institutions create what the Association of American Medical Colleges (AAMC) calls “an existential threat” to biomedical research, medical schools, and…
Continue Reading
Viraj Narayanan, CEO at Cornerstone AI
Daniel Lane, Head of RWD Strategy & Operations at Bristol Myers Squibb
Real-world data (RWD) has become the pharmaceutical industry’s most promising yet challenging frontier. While companies have long…
Continue Reading
The Problem with Traditional Mental Health Assessment
Neuroscience technology company Brooklyn Health is leveraging artificial intelligence to address a critical flaw in neurology and psychiatry: the unreliable approach to mental health outcomes measurement. The startup’s…
Brittany Erana, CEO at Jumo Health
What You Should Know:
– Jumo Health, a global leader in optimizing the patient experience in clinical trials announced the appointment of Brittany Erana as its new Chief Executive Officer.
–…
Continue Reading
Clinical practice is currently guided by studies that average over patient outcomes. This may not be the best approach, as different patients may have different treatment responses. Here we extend a method for simulating…
Continue Reading
What You Should Know:
– Vivodyne, a company pioneering an exclusively human-focused preclinical process, today announced it has raised $40M in new Series A funding led by Khosla Ventures, with participation from new investors Lingotto…
Continue Reading
Brooklyn Health, a neuroscience technology company, secured $6.5 million in seed funding. The round was led by HealthX, with participation from Metrodora Ventures, Story Ventures, RiverPark Ventures, Laconia Capital, Everywhere Ventures, Hypothesis Studio and Blue…
Continue Reading
What You Should Know:
– Brooklyn Health, a neuroscience technology company focused on objective measurement of mental health announced it has secured $6.5M in seed funding led by HealthX, with participation from Metrodora Ventures, Story…
Continue Reading
The prototype of a machine that can detect tumours in women with dense breast tissue has been developed in Newcastle.
It is part of a research programme being delivered by technology group, Kromek, in partnership…
